Bristol Myers Squibb to Present Data at ASCO & EHA from More

Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology and hematology portfolio at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Related Keywords

United States , Japan , South Korea , Taiwan , American , Pushkar Mutha , Mariat Bourlon , Tycel Jovelle Phillips , Tony Mok , Lin Wang , Peter Robert Galle , Charlene Mantia , Marc Hoffmann , Eric Christenson , Suzanne Trudel , Manali Kirtikumar Kamdar , Guillermo Garcia Manero , Martin Reck , Tina Cascone , Jonathan Spicer , Elena Elimova , Jeremy Abramson , Bristol Myers Squibb , Daniel Lin , Williamg Wierda , Andrewh Wei , Ian Chau , Francesco Passamonti , Antonis Kattamis , Claire Harrison , Bertrand Arnulf , Golcadomide Golca , Clara Amorosi , Paolo Antonio Ascierto , Aimaz Afrough , Kevin Kuo , Steveny Liu , David Valc , Sheida Hayati , Xavier Leleu , Saby George , Heinz Joseph Lenz , Matthewd Galsky , Esther Oliva , Valeria Santini , Manali Kamdar , Michael Amatangelo , Maria Teresa Voso , Amer Methqal Zeidan , Hemophagocytic Lymphohistiocytosis , Luca Malcovati , Mecide Meric Gharibo , Jennifer Rachel Eads , Michaela Postow , Samit Hirawat , Mark Pegram , Daniel Halperin , Sayed Matar , Dirk Schadendorf , John Cunningham , Husseina Tawbi , Julio Chavez , Patrick Connor Johnson , Omar Nadeem , Xin Wang , Alexander Drilon , Hans Lee , Kashyap Patel , Instagram , International Blood , Facebook , European Hematology Association , Acceleron Pharma Inc , Exchange Commission , Laboratory Abnormalities , Quality Care Health Services Research , Linkedin , Twitter , American Society Of Clinical Oncology , Drug Development , Marrow Transplant Research , Youtube , Ono Pharmaceutical Co , Drug Administration , Clinical Oncology , Annual Meeting , Bristol Myers , Important Safety Information , Prescribing Information , Boxed Warnings , Acceleron Pharma , Central Time , Myeloid Leukemia , Myelodysplastic Syndromes , Lymphocytic Leukemia , Chronic Lymphocytic Leukemia , Hodgkin Lymphoma , Expanded Access Protocol , Small Cell Lung Cancer , Previously Treated , Metastatic Non Small Cell Lung Cancer , Non Small Cell Lung Cancer , Non Small Cell Metastatic , Therapeutics Molecularly Targeted Agents , Tumor Biology , Cell Carcinoma , Eastern Daylight , Central European Time , Myers Squibb , Better Future , Fatal Immune Mediated Adverse , Full Prescribing Information , Allogeneic Hematopoietic Stem Cell , Multiple Myeloma , Thalidomide Analogue , Mediated Nephritis , Drug Rash , Adverse Reactions , Release Syndrome , Risk Evaluation , Mitigation Strategy , Neurologic Toxicities , Macrophage Activation Syndrome , Igg Secondary Malignancies , Operate Machinery , Lipase Elevation , Product Characteristics , Breakthrough Therapy Designations , Orphan Drug , Lung Disease , Creatine Phosphokinase , Ono Pharmaceutical , Profit Share Agreement , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports , Ihr Portfolio ,